
Richelle Flanagan realised that something wasn’t quite right when she was writing in a client’s record card during a dietetic consultation and she noticed that her hands were shaking. She was three months pregnant at the time.
Shortly after the birth of her daughter she was diagnosed with young onset Parkinson’s disease (YOPD), a form of Parkinson’s which starts between the age of 21 and 40.
The condition affects the nervous system and the parts of the body controlled by the nerves and while it mostly includes the same symptoms of Parkinson’s disease – tremor, slowness of movement, muscle stiffness and balance problems – it impacts young people differently due to their unique life circumstances.
Richelle, for instance, noticed that her Parkinson’s symptoms were getting worse the week before her menstrual bleed.
“Other women with YOPD were saying the same thing. As a dietitian, I’ve always had an inquisitive mind, so I started looking at the research.”
She discovered that oestrogen receptors in the brain impact neurotransmitters like dopamine, which people with Parkinson’s lack. When oestrogen and progesterone levels drop before a woman’s menstrual bleeding, she found, dopamine levels are impacted, leading to a worsening of the Parkinson’s symptoms.
It was an aha moment which inspired her to conduct a global survey of women with Parkinson’s to better understand the changes.
“I surveyed around 240 women and 80 per cent of them reported the same issues I had around the menstrual cycle.
“However, more concerning was the lack of awareness or advice by neurologists on how to manage the symptoms – no one was talking about these things.”
The gender gap, Richelle realised, was not just limited to “bikini medicine”.
‘Neurosexism’
Although Parkinson’s disease seems to occur more commonly in men than women, it is estimated that 40 per cent of people living with the disease worldwide are women.
Data shows there is a fundamental gap in knowledge in how Parkinson’s disease manifests and affects women throughout their hormonal life cycle, resulting in unmet needs and adversely impacting women’s quality of life.
Current literature is scarce and conflicting with how the disease affects women. There are currently no official guidelines on how to manage Parkinson’s symptoms in this group.
“Lisa Mosconi, a famous neuroscientist, calls this neurosexism,” says Richelle. “It’s exactly what it is.”
In Parkinson’s, she goes on to explain, the main drug that people are given is levodopa, a medication which was developed before the FDA required drug makers to look at the differences between men and women.
“Although research shows that the drug is absorbed 25 per cent more in women, which can lead to more side effects, nothing is being done to tailor it to women’s differing metabolism.”
The gaps in research, coupled with the growing rates of Parkinson’s in women, prompted Richelle to take action.
As part of a DayOne digital hackathon, she proposed the development of a digital health app to help women track their Parkinson’s symptoms and My Moves Matter was born.
The app, which Richelle says has a “neuro-friendly” design, aims to help women understand the impact of their hormones on their symptoms, recognise patterns and make lasting positive changes. It includes a journal feature, which allows users to detail their symptoms, and is currently the only digital app in the world that tracks neurological symptoms across the menstrual cycle.
More importantly, the platform seeks to help women connect with each other, learn more about their condition and get involved in research.

“I firmly believe that there’s so much more that we could find answers to, through understanding women,” Richelle explains.
“We can unlock a lot of answers through our biology. Rather than seeing it as a woman’s thing, we should be seeing it as a whole plethora of research that could improve outcomes for people of all genders and sexes.”
Research is already underway to improve the lives of women living with Parkinson’s. Researchers at University College Cork (UCC) have collaborated with My Moves Matter on a world-first study that could completely transform how women manage the disease.
Participants will be able to log their symptoms on the app to collect data which it is hoped will lead to better patient-specific treatment and management of Parkinson’s disease.
“Many people think Parkinson’s disease only affects older white men,” Richelle says.
“The reality is that 40 per cent of people living with Parkinson’s are women and up to 30 per cent are under the age of 60. And while Parkinson’s is the fastest growing neurological condition in the world, there are no clinical guidelines for the management of symptoms worsening in relation to hormonal changes in women.
“My hope is that this study may help to lay the foundations for the development of such guidelines.”
Additionally, the founder says the findings could help develop My Moves Matter into a “personalised” support platform for people with Parkinson’s.
“Parkinson’s is a very disabling diagnosis. Our aim is to offer everyone the support they need, whether it’s related to diet, exercise or mental health, because there’s no cure for it, and there are no drugs to slow progression at the moment.
“I believe in empowering people and that’s what we ultimately want to do.”
The app can be found on mymovesmatter.com. You can participate in the study by filling out this survey.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









